Taletrectinib
October 2023
ESMO 2023 Poster Presentation
March 2023
ELCC 2023 Mini Oral Presentation
Updated Efficacy and Safety of Taletrectinib in Patients with ROS1+ Non–Small Cell Lung Cancer (pdf)
March 2023
Future Oncology
PMID: 36877099
June 2022
ASCO 2022 Poster Presentation
April 2022
ELCC 2022 Poster Presentation
Sept 2021
CSCO 2021 Oral Presentation
June 2021
ASCO 2021 Poster Presentation
October 2020
JTO Clinical and Research Reports
PMID: 34589973 PMCID: PMC8474193 DOI: 10.1016/j.jtocrr.2020.100108
September 2020
Clinical Cancer Research
PMID: 32591465 DOI: 10.1158/1078-0432.CCR-20-1630
August 2019
Nature Communications
PMID: 31399568 PMCID: PMC6688997 DOI: 10.1038/s41467-019-11496-z
May 2018
Oncotarget
PMID: 29805770 PMCID: PMC5955103 DOI: 10.18632/oncotarget.25263
Safusidenib
June 2022
Neuro-Oncology
February 2020
Molecular Cancer Therapeutics